Lin Shang Peng Li Jie Fan Chunning Zhao Xiangying Niu Qitian Bian Zhilin Yuan Yanlong Kong Tingshun Zhu Bin Xu Jianxin Dong Hongjun Xiang
10.3389/fimmu.2022.946266
Front Immunol
2022 Sep 20;13:946266.
pd-1 antibody chemotherapy downstaging therapy immunotherapy unresectable advanced pancreatic cancer
CC BY
https://pubmed.ncbi.nlm.nih.gov/36203575/
Adenocarcinoma / drug therapy Pancreatic Neoplasms / drug therapy
Adenocarcinoma / drug therapy Pancreatic Neoplasms / drug therapy Case Reports Adult B7-H1 Antigen Humans Male Microsatellite Repeats Middle Aged Programmed Cell Death 1 Receptor B7-H1 Antigen Programmed Cell Death 1 Receptor Pancreatic Carcinoma
PMC9530699
36203575
Case report: Two PD-L1 positive unresectable advanced pancreatic carcinoma patients with microsatellite stability achieved R0 resection after PD-1 antibody plus chemotherapy as a successful downstaging therapy: A report of two cases
2022